Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-07-14Clinical Trial Update: A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing calcium channel blockers with Angiotensin II receptor antagonists in patients with hypertension and type 2 diabetes;…
-
FDA approval · 2006-07-03FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…
-
FDA approval · 2006-06-20FDA Approved: QUINAPRIL — Original Application (BluePoint Laboratories)
FDA approved the original ANDA for Quinapril from BluePoint Laboratories, establishing a generic version of the ACE inhibitor used to treat …
-
FDA approval · 2006-06-16FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) submitted by Almatica Pharma Inc.
-
FDA approval · 2006-06-08FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for lisinopril and hydrochlorothiazide from GSMS, Incorporated, confirming approval of a generic fix…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-06-08FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…
-
FDA approval · 2006-06-07FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for doxazosin (generic), confirming regulatory clearance related to this generic p…
-
CLINICAL_TRIALS research · 2006-05-31Clinical Trial Update: Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility [NA]
This clinical trial update investigates hypertension-related microcirculation damage in South Asians, focusing on how it emerges, its predic…
-
FDA approval · 2006-05-26FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for the Atenolol and chlorthalidone combination from Actavis Pharma, Inc.
-
CLINICAL_TRIALS research · 2006-05-26Clinical Trial Update: Effects of Low Salt Diet Versus High Salt Diet on Blood Pressure [NA]
An Aga Khan University-led clinical trial investigates the effects of low-salt versus high-salt diets on blood pressure in adults with hyper…
-
CLINICAL_TRIALS research · 2006-05-26Clinical Trial Update: Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive Medication [NA]
A clinical trial update examining whether training general practitioners improves adherence to antihypertensive medications among people wit…
-
CLINICAL_TRIALS research · 2006-05-26Clinical Trial Update: Population Based Strategies for Effective Control of High Blood Pressure in Pakistan [NA]
A clinical trial update describing population-based strategies to improve control of high blood pressure in Pakistan; no results or status d…
-
FDA approval · 2006-05-04FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.